Cordlife Group Limited (CLIFF)
OTCMKTS
· Delayed Price · Currency is USD
0.1157
0.00 (0.00%)
May 13, 2025, 4:00 PM EDT
Cordlife Group Revenue
In the year 2024, Cordlife Group had annual revenue of 27.84M SGD, down -50.04%. Cordlife Group had revenue of 18.65M in the half year ending December 31, 2024, a decrease of -35.50%.
Revenue
27.84M SGD
Revenue Growth
-50.04%
P/S Ratio
1.50
Revenue / Employee
51.75K SGD
Employees
538
Market Cap
30.62M USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.84M | -27.89M | -50.04% |
Dec 31, 2023 | 55.73M | 574.00K | 1.04% |
Dec 31, 2022 | 55.16M | -1.51M | -2.67% |
Dec 31, 2021 | 56.67M | -2.32M | -3.93% |
Dec 31, 2020 | 58.99M | -2.59M | -4.21% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |